Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Giles

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|June 28, 2001
Cost-Effectiveness of interferon alfa-2b added to chemotherapy for high-tumor-burden follicular non-Hodgkin's lymphomaD P Wirt, F J Giles, M M Oken, et al.
British Journal of Cancer|April 30, 2009
Targeting HSP90 for cancer therapyD Mahalingam, R Swords, J S Carew, et al.
Leukemia & Lymphoma|November 9, 2001
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndromeS Verstovsek, E Estey, T Manshouri, et al.
Leukemia & Lymphoma|June 1, 1995
Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferationA P Jewell, P M Lydyard, C P Worman, et al.
Cancer|January 29, 2000
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapyK Kaban, H Kantarjian, M Talpaz, et al.
Cancer Genetics and Cytogenetics|October 15, 1988
Granulocytic sarcoma of the small intestine preceding acute myelomonocytic leukemia with abnormal eosinophils and inv(16)S J Russell, F J Giles, D S Thompson, et al.
Cancer Genetics and Cytogenetics|July 2, 1998
Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicatorsF J Giles, T J Kanemaki, R R Schreck, et al.
Leukemia & Lymphoma|March 18, 2000
Oral idarubicin in patients with late chronic phase chronic myelogenous leukemia or chronic myelomonocytic leukemiaF J Giles, G C Wong, S J Clark, et al.
Cancer|August 27, 1999
Multidrug resistance protein expression in chronic myeloid leukemia: associations and significanceF J Giles, H M Kantarjian, J Cortes, et al.
Acta Haematologica|January 1, 1988
Atypical mycobacterial infection in alpha interferon-treated hairy cell leukaemiaF J Giles, S J Russell, C P Worman, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|June 28, 2001
Cost-Effectiveness of interferon alfa-2b added to chemotherapy for high-tumor-burden follicular non-Hodgkin's lymphomaD P Wirt, F J Giles, M M Oken, et al.
British Journal of Cancer|April 30, 2009
Targeting HSP90 for cancer therapyD Mahalingam, R Swords, J S Carew, et al.
Leukemia & Lymphoma|November 9, 2001
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndromeS Verstovsek, E Estey, T Manshouri, et al.
Leukemia & Lymphoma|June 1, 1995
Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferationA P Jewell, P M Lydyard, C P Worman, et al.
Cancer|January 29, 2000
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapyK Kaban, H Kantarjian, M Talpaz, et al.
Cancer Genetics and Cytogenetics|October 15, 1988
Granulocytic sarcoma of the small intestine preceding acute myelomonocytic leukemia with abnormal eosinophils and inv(16)S J Russell, F J Giles, D S Thompson, et al.
Cancer Genetics and Cytogenetics|July 2, 1998
Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicatorsF J Giles, T J Kanemaki, R R Schreck, et al.
Leukemia & Lymphoma|March 18, 2000
Oral idarubicin in patients with late chronic phase chronic myelogenous leukemia or chronic myelomonocytic leukemiaF J Giles, G C Wong, S J Clark, et al.
Cancer|August 27, 1999
Multidrug resistance protein expression in chronic myeloid leukemia: associations and significanceF J Giles, H M Kantarjian, J Cortes, et al.
Acta Haematologica|January 1, 1988
Atypical mycobacterial infection in alpha interferon-treated hairy cell leukaemiaF J Giles, S J Russell, C P Worman, et al.
Pageof 13